Cited in:


This article has been cited by:

  1. 1
    Kristina Sundquist, Jan Sundquist, Jianguang Ji, Risk of hepatocellular carcinoma and cancers at other sites among patients diagnosed with chronic hepatitis B virus infection in Sweden, Journal of Medical Virology, 2014, 86, 1
  2. 2
    Jie Dai, En-Qiang Chen, Lang Bai, Dao-Yin Gong, Qiao-Ling Zhou, Xing Cheng, Fei-Jun Huang, Hong Tang, Biological characteristics of the rtA181T/sW172* mutant strain of Hepatitis B virus in animal model, Virology Journal, 2012, 9, 1, 280


  3. 3
    Nan Jiang, Hua LI, Gen-Shu Wang, Jian Zhang, Jun-Feng Zhang, Shu-Hong Yi, Yang Yang, Chang-Jie Cai, Min-Qiang Lu, Gui-Hua Chen, Acute leukemia, a rare but fatal complication after liver transplantation, Leukemia Research, 2009, 33, 10, 1349


  4. 4
    Nadia Warner, Stephen Locarnini, The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound, Hepatology, 2008, 48, 1
  5. 5
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2005, 14, 7